Drug Pricing, Medicaid, and Research Funding: Critical Policy Issues in the Midterms
Daniel Payne
Summary
The upcoming midterm elections could bring significant changes to U.S. healthcare policy, with major implications for drug pricing, Medicaid coverage, and medical research funding. Different political outcomes may alter how pharmaceutical companies price medications and how hospitals deliver care to patients. These policy shifts could directly affect medication affordability and access to treatment for millions of Americans, including Puerto Rico residents who rely on Medicaid. The election results will shape whether drug prices become more regulated and how research funding supports the development of new treatments for various health conditions.
